BAM
THC icon

Belpointe Asset Management’s Tenet Healthcare THC Stock Holding History

Belpointe Asset Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$643K Buy
3,438
+271
+9% +$49.8K 0.02% 636
2026
Q1 		$598K Sell
3,167
-562
-15% -$118K 0.02% 635
2025
Q4 		$741K Buy
3,729
+71
+2% +$14.3K 0.03% 540
2025
Q3 		$743K Buy
3,658
+596
+19% +$106K 0.03% 502
2025
Q2 		$539K Buy
3,062
+1,075
+54% +$162K 0.02% 553
2025
Q1 		$267K Sell
1,987
-248
-11% -$32.7K 0.01% 761
2024
Q4 		$368K Sell
2,235
-946
-30% -$141K 0.02% 589
2024
Q3 		$529K Buy
+3,181
New +$481K 0.03% 488
2023
Q2 		– Sell
-588
Closed -$34.9K – 3105
2023
Q1 		$34.9K Buy
588
+285
+94% +$15.8K ﹤0.01% 1943
2022
Q4 		$14.8K Buy
+303
New +$14K ﹤0.01% 2409

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Belpointe Asset Management's THC Position: Q2 2026 in Review

Belpointe Asset Management increased its Tenet Healthcare (THC) stake by 8.6% in Q2 2026, buying an estimated $49.8K and bringing the position to 3,438 shares worth $643K. The position accounts for 0.02% of the portfolio, ranked #636.

Belpointe Asset Management first reported a position in THC in Q4 2022 and has held it in 10 quarters since. The position peaked at $743K in Q3 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Belpointe Asset Management held 3,438 shares of Tenet Healthcare worth $643K as of Q2 2026.
  • Belpointe Asset Management bought 271 Tenet Healthcare shares in Q2 2026, an estimated $49.8K.
  • Tenet Healthcare made up 0.02% of Belpointe Asset Management's portfolio in Q2 2026, its #636 holding.
  • Belpointe Asset Management first reported a position in Tenet Healthcare in Q4 2022 and has held it in 10 quarters since.
  • Belpointe Asset Management's Tenet Healthcare position peaked at $743K in Q3 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.